Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Estera Okoń
Observed name:
Estera Okon
Institution:
Medical University of Lublin
Observed institution:
Medical University of Lublin
ORCID:
0000-0003-3810-8247
Observed ORCID:
0000-0003-3810-8247
OpenAlex ID:
A5033920163
Vorinostat (SAHA) and Breast Cancer: An Overview
2021
·
Anna Wawruszak
, Lidia Borkiewicz
, et al.
·
Cancers
·
132
PDF
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
2019
·
Anna Wawruszak
, Joanna Kalafut
, et al.
·
Cancers
·
106
Valproic Acid and Breast Cancer: State of the Art in 2021
2021
·
Anna Wawruszak
, Marta Halasa
, et al.
·
Cancers
·
85
PDF
Advances in Chemistry and Bioactivity of Magnoflorine and Magnoflorine-Containing Extracts
2020
·
Estera Okon
, Wirginia Kukula-Koch
, et al.
·
International Journal of Molecular Sciences
·
82
PDF
MicroRNAs-Role in Lung Cancer
2014
·
Małgorzata Guz
, Adolfo Rivero-Müller
, et al.
·
Disease Markers
·
78
PDF
Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells
2020
·
Estera Okon
, Wirginia Kukula-Koch
, et al.
·
Biomolecules
·
49
PDF
Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells
2022
·
Anna Wawruszak
, Jarogniew Luszczki
, et al.
·
Cells
·
27
PDF
Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin
2020
·
Estera Okon
, Jarogniew J. Luszczki
, et al.
·
International Journal of Molecular Sciences
·
27
PDF
Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
2019
·
Anna Wawruszak
, Ewelina Gumbarewicz
, et al.
·
Cancer Management and Research
·
22
PDF
Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies
2025
·
Anna Wawruszak
, Jarogniew Luszczki
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
20
Fucoxanthin: From chemical properties and sources to novel anticancer mechanistic insights and synergistic therapeutic opportunities
2024
·
Wojciech Koch
, Wirginia Kukula-Koch
, et al.
·
Current Research in Biotechnology
·
16
Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer
2023
·
Estera Okon
, Katarzyna Gawel-Beben
, et al.
·
International Journal of Molecular Sciences
·
15
PDF
Chemopreventive and Anticancer Activity of Selected Triterpenoids in Melanoma
2025
·
Natalia Dycha
, Magdalena Michalak-Tomczyk
, et al.
·
Cancers
·
13
PDF
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identification and Drug Targeting, and Developments in Personalized Medicine in Breast Cancer
2023
·
Anna Wawruszak
, Estera Okoń
, et al.
·
Medical Science Monitor
·
13
PDF
Vaccinium Species—Unexplored Sources of Active Constituents for Cosmeceuticals
2024
·
Wirginia Kukula-Koch
, Natalia Dycha
, et al.
·
Biomolecules
·
12
Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models
2021
·
Marta Hałasa
, Jarogniew J. Łuszczki
, et al.
·
International Journal of Molecular Sciences
·
12
PDF
Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis
2022
·
Anna Wawruszak
, Jarogniew Luszczki
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together
2021
·
Anna Wawruszak
, Jarogniew Luszczki
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells
2022
·
Anna Wawruszak
, Estera Okon
, et al.
·
Pharmacological Reports
·
8
PDF
Emodin-8-O-Glucoside—Isolation and the Screening of the Anticancer Potential against the Nervous System Tumors
2023
·
Estera Okon
, Maryna Koval
, et al.
·
Molecules
·
6
PDF
The Activity of 1,8-Dihydroanthraquinone Derivatives in Nervous System Cancers
2024
·
Estera Okoń
, Wirginia Kukula-Koch
, et al.
·
Molecules
·
3
PDF
Purification of Lepidilines A, B, C, and D from Lepidium meyenii Walpers by Centrifugal Partition Chromatography Followed by Semi-Preparative HPLC and Preliminary Evaluation of Anticancer Activity Against Neuroblastoma Cell Lines
2025
·
Dominik Tarabasz
, Estera Okoń
, et al.
·
Molecules
·
2
PDF
MMP-9 and MMP-2 regulation in patients undergoing non-oncological and non-vascular elective surgery independent of the use of propofol or sevoflurane
2019
·
Michał Kowalczyk
, Małgorzata Guz
, et al.
·
Pharmacological Reports
·
2
Beyond the Well-Known Phytochemicals: Cryptic Plant-Derived Histone Acetyltransferase (HAT) and Histone Deacetylase (HDAC) Modulators as Epigenetic Adjuvants in Cancer Therapy
2026
·
Estera Okoń
, Agata Jarząb
, et al.
·
Cells
Physapubescin B From Physalis: A Food‐Derived Withanolide for Cancer Chemoprevention and Nutraceutical Development
2026
·
Wojciech Koch
, Katarzyna Stępnik
, et al.
·
eFood
PDF
Show more works
View as search
Works count:
25
Citation count:
752
H-index:
13
I10-index:
18
Year
Topic
Type